Skip to main content
Displaying 13 - 24 of 26
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
What can we learn about holistic care to manage cholestatic pruritus in PBC from a US healthcare setting?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Closing remarks
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Final audience questions
Webcasts
View
Immune-Mediated and Cholestatic Diseases
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Introduction
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Case Based Discussion on Biochemical Normalization
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Case Based Discussion on QOL/Pruritus
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Conclusion
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What Is on the Horizon? Emerging Treatments
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Q&A and Close
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Chair’s Welcome and Introduction
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
Page
3
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy